Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

11 Jun 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260611210092/en/Johnson-Johnson-Expands-U.S.-Availability-of-TECNIS-PureSee-IOL-an-Advanced-Lens-Option-for-Cataract-Surgeons-and-Patients

11 Jun 2026
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/jj-shows-results-trial-could-lead-rare-disease-expansion-imaavy

08 Jun 2026
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-buy-firefly-bio-1-billion-2026-06-08/

03 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/johnson--johnson-presents-new-data-further-reinforcing-the-role-of-nipocalimab-in-lowering-the-autoantibodies-driving-sjogrens-disease-302789435.html

03 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/johnson--johnson-late-breaking-results-show-nipocalimab-significantly-reduced-systemic-lupus-erythematosus-sle-disease-activity-in-a-phase-2-study-302789438.html

31 May 2026
// PRESS RELEASE
https://www.jnj.com/media-center/press-releases/rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-pivotal-data-show-strong-and-durable-responses-in-advanced-head-and-neck-cancer-where-options-remain-limited
Excipients
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
Johnson & Johnson is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find Nicotine bulk with DMF offered by Johnson & Johnson
Find Naloxone Hydrochloride bulk offered by Johnson & Johnson
Find Sodium Hyaluronate bulk offered by Johnson & Johnson